Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/22/2008CN101289511A Multivalent antibodies and uses therefore
10/22/2008CN101289510A Anti-CD40 monoclonal antibody
10/22/2008CN101289509A Novel method for preparing monoclonal antibody
10/22/2008CN101289508A Monoclonal antibody for preventing enterohemorrhagic escherichia coli O157:H7A/E from forming damnification
10/22/2008CN101289504A Bone marrow regeneration regulatory protein BRRG-1, encoding gene thereof and uses thereof
10/22/2008CN100427505C Receptor DR5 monoclonal antibody (AD5-10) resisting human tumor necrosin related apoptosis inducing ligand and its prepn and use
10/22/2008CN100427504C TNF alpha high-affinity chimeric antibody and use thereof
10/21/2008US7439333 Vascular endothelial growth factor 2
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439330 Binds to epitope which includes lysine; attached to a detectable label; antigen binding fragment is lyophilized; use in diagnosis and treatment of diabetic conditions
10/21/2008US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase
10/21/2008US7439325 PRO6001 polypeptides
10/21/2008US7439324 amyotrophic lateral sclerosis-specific epitope is conjugated to keyhole limpet hemocyanin; biodrug for eliciting immune response in animal to produce antibody; use in diagnosis, prognosis and therapeutic intervention in neurodegenerative Alzheimer's disease, Parkinson's disease, Huntington's disease
10/21/2008US7439319 Selective substrates for matrix metalloproteinases
10/21/2008US7439230 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease
10/21/2008US7439041 Prion-specific peptide reagents
10/21/2008US7439025 Antibodies binding a gamma carboxyglutamic acid displaying epitope
10/21/2008US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
10/21/2008US7438913 Administering polypeptide which binds to interleukins; skin disorders, antiallergens, aids
10/21/2008US7438911 Antibody against human insulin-like growth factor
10/21/2008US7438910 Quantitative analysis of interleukins in sample using monoclonal antibodies; antiinflammatory agents; antiarthritic agents
10/21/2008US7438908 Antitumor agents
10/21/2008US7438907 and inhibits IL-2 binding to CD25; can be produced by a hybridoma, a transfectoma or in a nonhuman transgenic animal; treating diseases including organ, tissue and cell transplant rejection, autoimmune diseases, inflammatory and hyperproliferative skin disorders, and lymphoid neoplasms
10/21/2008US7438906 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
10/21/2008US7438905 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants
10/21/2008CA2495581C Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes
10/21/2008CA2387383C Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
10/21/2008CA2232242C Long wavelength engineered fluorescent proteins
10/21/2008CA2220226C Improved methods for transfecting t cells
10/21/2008CA2042064C C-erbb-2 external domain:gp75
10/17/2008CA2584934A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof
10/16/2008WO2008124570A1 Methods for inhibiting the binding of endosialin to ligands
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008123948A1 Biomarkers for ovarian cancer
10/16/2008WO2008123538A1 Method for measurement of methylation in dna
10/16/2008WO2008123537A1 Method for measurement of methylation in dna
10/16/2008WO2008122886A2 Transgenic non-human mammal with homodimeric vh binding complex
10/16/2008WO2008122551A2 Anti-epcam antibody and uses thereof
10/16/2008WO2008122441A2 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/16/2008WO2008106116A3 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
10/16/2008WO2008104184A3 Method for cloning cognate antibodies
10/16/2008WO2008103953A3 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1)
10/16/2008WO2008101985A3 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
10/16/2008WO2008100578A3 Method of isolating antibodies by precipitation
10/16/2008WO2008099178A3 Binding members for ige molecules
10/16/2008WO2008093225A3 Sub -population of hematopoietic stem cells that express the crisp-1 protein
10/16/2008WO2008086395A3 Anti-il-13 antibody formulations and uses thereof
10/16/2008WO2008076857A3 Method and compositions for inhibiting mage protein interaction with kap-1
10/16/2008WO2008076560A3 Human monoclonal antibodies to btla and methods of use
10/16/2008WO2008064072A3 Anti-tsg101 antibodies and their uses for treatment of viral infections
10/16/2008WO2008063493A3 Compositions and methods related to toll-like receptor-3
10/16/2008WO2008049106A3 Process for preparing unaggregated antibody fc domains
10/16/2008WO2008028946A3 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
10/16/2008WO2008013953A3 Tyrosine phosphorylation sites
10/16/2008WO2008011107A3 Antagonists of protease activated receptor-1 (par1)
10/16/2008WO2007117505A3 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/16/2008WO2007103469A3 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/16/2008WO2007087576A3 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
10/16/2008WO2007014073A3 Concentrated protein lyophilates, methods, and uses
10/16/2008WO2007012944A9 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/16/2008WO2006078717A3 Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
10/16/2008US20080256649 Insect hydrolase for use as tool in identifying modulators which prevent mosquito propagation; genetic detection of resistance to organophosphorus and/or carbamates pesticides
10/16/2008US20080255342 Protein purification method
10/16/2008US20080255341 High throughput screening; immunoassays; immunogens; antibodies producing uridine diphosphate with higher affinity to carbohydrates
10/16/2008US20080255040 Polypeptide with amino acid sequences including exogenous glycosylated sequences; libraries
10/16/2008US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE
10/16/2008US20080254512 Hybrid immunoglobulins with moving parts
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254466 Heregulin-like Factor
10/16/2008US20080254440 Anti-Sars Virus Antibody, Hybridoma Producing the Antibody and Immunoassay Reagent Using the Antibody
10/16/2008US20080254070 Bacterial secreted protein for use in generating vaccine for prevention of streptococcal infection; immunotherapy
10/16/2008US20080254048 He4 monoclonal antibodies and methods for their use
10/16/2008US20080254047 Activation of Human Antigen-Presenting Cells Through CLEC-6
10/16/2008US20080254044 Immunoglobulin fusion comprising cohesin-dockerin for use in targeting, treating and preventing cell proliferative disorders
10/16/2008US20080254041 Raising immunoglobulins with high specificity for environmental and/or commercial allergens
10/16/2008US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders
10/16/2008US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection
10/16/2008US20080254033 Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases
10/16/2008US20080254032 Colony stimulating bfcator specific monoclonal antibody for use in diagnosis, prevention and treatment of infcetion, cell proliferative, inflammatory, autoimmune, arthritic, skin, respiratory and nervous system disorders
10/16/2008US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254027 Optimized CD5 antibodies and methods of using the same
10/16/2008US20080254026 Tumor necrosis factor specific immunoglobulin for use in classification, treatment and prevention of autoimmune, liver, arthritic, skin and cell proliferative disorders
10/16/2008US20080254025 Using interleukin-1( IL-1) specific immunoglobulin for diagnosis, prevention and treatment of osteoarthritic, inflammatory, respiratory and autoimmune disorders
10/16/2008US20080254024 Anti-ephb2 antibodies and methods using same
10/16/2008US20080254021 Tie1-binding ligands
10/16/2008US20080254020 Protein fusions comprising immunoglobulin regions exhibiting improved bioefficacy in multidose administration for use in treatment of infection, cell proliferative, autoimmune and inflammatory disorders
10/16/2008US20080253962 Irta-4 Antibodies and Their Uses
10/16/2008CA2682726A1 Methods for inhibiting the binding of endosialin to ligands
10/16/2008CA2682296A1 Anti-epcam antibody and uses thereof
10/15/2008EP1980616A2 E.Coli 0157: H7 C1 esterase inhibitor-binding protein STCE and uses thereof
10/15/2008EP1980573A2 Isolated dendritic cell membrane protein genes
10/15/2008EP1980570A2 Purification of Antibodies
10/15/2008EP1980269A1 Prevention of staphylococcus biofilm formation
10/15/2008EP1980267A1 S. pneumoniae transcytosis protein
10/15/2008EP1979379A2 Carbonic anhydrase ix (g250) antibodies and methods of use thereof
10/15/2008EP1979378A2 Novel collection of hcdr3 regions and uses therefor
10/15/2008EP1978993A2 Compositions and methods for diagnosing and treating cancer
10/15/2008EP1978985A2 Anti-hyperproliferative therapies targeting hdgf
10/15/2008EP1978974A1 Methods of treating degenerative disorders with rac 1b inhibitor
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 1494